A man who lost his ability to speak because of ALS just told his wife “I love you” using only his thoughts, and the moment was captured on video by Neuralink.
Story Snapshot
- Neuralink released a video called “Speaking With The Mind,” showing a participant using a brain implant to generate spoken words.
- The participant, identified as Kenneth, has amyotrophic lateral sclerosis (ALS) and is enrolled in Neuralink’s VOICE clinical trial.
- The device reportedly uses 3,000 channels placed in the brain’s speech motor region to decode intended speech in real time.
- Terry’s spouse says in the video, “You just got your voice back,” after he spoke phrases through the implant.
- The demonstration builds on earlier Neuralink voice-trial updates involving another participant who used the system to say “I love you.”
What The Video Actually Shows
Neuralink posted the short video on its YouTube channel under the title “Speaking With The Mind.” It shows a man named Terry, who has ALS, using a brain implant to produce spoken words again. Reporting from mid-September 2026 describes the clip as an emotional first-person account of regaining a lost ability.
Terry’s case sits inside Neuralink’s VOICE trial, a study built to test whether brain signals tied to attempted speech can be decoded and turned into audible words. According to the video’s transcript, the implant carries 3,000 channels placed directly in the brain’s speech motor region. The system reads neural activity as Terry tries to say phrases like “Hello, how are you doing today?”
Why This Case Carries Extra Weight
ALS slowly destroys a person’s ability to control muscles, including the ones needed for speech. For many patients, losing the power to talk is one of the disease’s cruelest blows. Terry’s wife says in the video, “That’s one of my biggest fears is that I’ll lose that ability to communicate with him and know instinctively what he’s needing.”
That fear frames why the demonstration matters beyond the technology itself. Terry tells viewers, “Neuralink has given me back my voice.” His spouse responds, “You just got your voice back.” Those words, spoken through a machine reading his brain, land differently than a scripted product demo ever could.
Part Of A Longer Pattern Of Public Milestones
This is not Neuralink’s first public voice-trial reveal. Earlier company updates referenced a participant named Kenneth, described as the second person in the voice study, who reportedly used the system to say “I love you” and “I’m talking to you with my mind.” Those releases followed the same format: a short video, a personal quote, and a wave of coverage.
The company has also picked up regulatory recognition along the way. In May 2025, the Food and Drug Administration (FDA) granted Neuralink’s speech restoration device a Breakthrough Device designation, a status meant to speed review of technology that could meaningfully help patients with serious conditions. That designation does not mean the device has full approval, but it does signal the government sees real promise here.
Context From The Wider Brain-Interface Field
Neuralink’s video fits a pattern seen across brain-computer interface research generally. Peer-reviewed reviews of the field note that most clinical evidence so far comes from small, case-based studies rather than large controlled trials. Researchers have flagged that media coverage sometimes runs ahead of the underlying data, inflating expectations for a technology still working through early clinical stages.
That broader caution is useful background, not a knock on what Terry experienced. His words were his own, generated through a device implanted in his brain, and his family’s relief was real. The company controls how these moments get released to the public, and fuller trial data would let outside experts weigh the results with more precision over time.
What Comes Next For The VOICE Trial
Neuralink has not published detailed accuracy rates, response-time measurements, or long-term usage data tied to this specific demonstration. What the public has is the video, the transcript, and the family’s own account of what changed for them. For ALS patients and their loved ones watching this unfold, that alone represents a meaningful update worth tracking.
As the VOICE trial continues, more participants and more public updates are likely. Each new release will add to a growing record of what this technology can do for people who have lost their ability to speak, and how consistently it can deliver that outcome across different patients and stages of disease.
A PARALYZED MAN TRAPPED IN TOTAL SILENCE JUST SPOKE TO HIS WIFE AGAIN 🚨🧠🗣️@neuralink shared a 23-second video that marked a turning point in human history: an ALS patient named Kenneth Shock speaking to his wife.
Kenneth was diagnosed in 2024 with ALS, a cruel condition that… https://t.co/DP62lpkYgA
— ilmeaalim.eth (@ilmeaalim) September 18, 2026
For families facing ALS today, the promise on display is simple and profound: a way to keep talking to the people they love, even after the disease takes their voice.
Sources:
explainx.ai, thehansindia.com, basenor.com, teslanorth.com, benzinga.com
